Infant lymphoblastic leukemia: a single centers 10 year experience


Creative Commons License

Yaman-Bajin I., Aytac Ş. S., Kuskonmaz B. B., Uckan-Cetinkaya D., ÜNAL Ş., GÜMRÜK F., ...Daha Fazla

TURKISH JOURNAL OF PEDIATRICS, cilt.61, sa.3, ss.325-329, 2019 (SCI-Expanded, Scopus, TRDizin) identifier identifier identifier

Özet

Infant acute lymphoblastic leukemia (ALL) is a rare disease and consists of 4-5% of all childhood ALL. Despite improved survival rates in childhood ALL, infants with ALL have a worse prognosis. We aimed to evaluate the clinical features and treatment outcomes of our patients diagnosed with infant ALL at Hacettepe University, Pediatric Hematology Department between 1 January 2008 and 1 January 2018 retrospectively.